Forefront Analytics »

Travere Therapeutics shares owned by Forefront Analytics

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Forefront Analytics from 13F filings

Historical chart of Forefront Analytics investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Forefront Analytics consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Forefront Analytics

Quarter filed Position value Share count Share price at filing
2024-03-31 $93k 12k 7.71

More positions owned by Forefront Analytics

Ishares Tr Esg Aw Msci Eafe (ESGD)
Nushares Etf Tr Nuveen Esg Lrgvl (NULV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Flexshares Tr Stox Gbl Esg Slt (ESGG)
Barclays Bank Djubs Cmdt Etn36 (DJP)
First Tr Exchange-traded No Amer Energy (EMLP)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard World Extended Dur (EDV)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Ishares Tr Jpmorgan Usd Emg (EMB)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)

View all positions for Forefront Analytics

Top funds holding Travere Therapeutics

BlackRock
Armistice Capital
Vanguard Group
Morgan Stanley
Rock Springs Capital Management
Deutsche Bank Aktiengesellschaft
Pictet Asset Management Holding SA
Millennium Management
Kynam Capital Management
D. E. Shaw & Co
Emerald Advisers
Bank of America Corporation
Finepoint Capital
Geode Capital Management
Emerald Mutual Fund Advisers, Trust

View all funds holding Travere Therapeutics